Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
106 hedge funds and large institutions have $109M invested in Zomedica Corp. in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 27 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 15
15% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 27
4% more funds holding
Funds holding: 102 → 106 (+4)
31% less capital invested
Capital invested by funds: $157M → $109M (-$48.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$12.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$12.1M |
| 3 |
Swiss National Bank
Zurich,
Switzerland
|
+$1.85M |
| 4 |
Morgan Stanley
New York
|
+$1.84M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$3.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.43M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.19M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$1.31M |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$1.04M |
ZOM Hedge Fund Activity: Q2 2021 in Review
106 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2021, worth a combined $109M — down 31% from $157M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ZOM positions and 27 closed out — a net gain of 4 holders — while 26 added to existing stakes and 15 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $12.5M. The largest seller was HRT Financial, exiting entirely with an estimated $3.6M sold.
- 106 institutional investors held Zomedica Corp. (ZOM) as of Q2 2021, up from 102 in Q1 2021.
- Funds reported $109M of Zomedica Corp. stock for Q2 2021, down 31% quarter-over-quarter.
- 31 funds opened new Zomedica Corp. positions in Q2 2021 and 27 closed out, a net change of +4 holders.
- The largest Zomedica Corp. buyer in Q2 2021 was Renaissance Technologies, an estimated $12.5M added.
- The largest Zomedica Corp. seller in Q2 2021 was HRT Financial, an estimated $3.6M sold.
Based on aggregated 13F filings for Q2 2021.